PLA2R1 and membranous glomerulonephritis: In 2009, Beck et al. (2009) first discovered that M-type phospholipase A2 receptor (PLA2R) was a key target glomerular podocyte antigen, which was abundantly expressed in 70% of patients with primary membranous nephropathy (MN).